Patent · US Active

Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

US8217040B2 · kind B2 · utility

4Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2006
Grant dateJul 10, 2012
Priority date—
Expiry dateSep 21, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present patent application relates to the use of triazine derivatives as cicatrising or angiogenic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.